Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check7 days agoChange DetectedThe webpage has updated its contact information, replacing Dr. Joseph Treat with Dr. Joseph Bodor, including new phone numbers and email addresses. Additionally, the dates have been updated to reflect the current timeline.SummaryDifference0.9%
- Check15 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new interventional model description for a clinical trial involving non-small cell lung cancer, and the removal of extensive background information on lung cancer treatment and patient eligibility criteria.SummaryDifference66%
- Check22 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 11, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.2%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check44 days agoChange DetectedThe webpage has updated its date-related content, removing several past dates and adding new future dates, indicating a shift in the timeline of events or updates.SummaryDifference0.8%
Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.